Patrick G Enright - Net Worth and Insider Trading

Over the past 18 months, Patrick G Enright made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aptinyx Inc (APTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptinyx Inc (APTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aptinyx Inc (APTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc (MTEM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Jennifer E. Cook .

In summary, during the past 3 months, insiders sold 2,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 2,410 shares. During the past 18 months, 34,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 22,900 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,281,265 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,114,598 shares were bought by its insiders, resulting in a net purchase of 2,107,075 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in 89bio Inc (ETNB). Other recent insider transactions involving 89bio Inc (ETNB) include a net sale of 72,195 shares made by Rohan Palekar , a net sale of 41,638 shares made by Quoc Le-nguyen , and a net purchase of 1,350,000 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 27,955 shares of 89bio Inc (ETNB) in total and bought 0 shares, with a net sale of 27,955 shares. During the past 18 months, 132,583 shares of 89bio Inc (ETNB) were sold and 1,350,000 shares were bought by its insiders, resulting in a net purchase of 1,217,417 shares.

89bio Inc (ETNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 268,266 shares made by Grant Pickering , a net sale of 152,000 shares made by Andrew Guggenhime , and a net sale of 66,000 shares made by Jim Wassil .

In summary, during the past 3 months, insiders sold 209,515 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 209,515 shares. During the past 18 months, 598,563 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 598,563 shares.

Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Venus Concept Inc (VERO). Other recent insider transactions involving Venus Concept Inc (VERO) include a net sale of 958,979 shares made by Michael Willingham Masters ,

In summary, during the past 3 months, insiders sold 469,031 shares of Venus Concept Inc (VERO) in total and bought 0 shares, with a net sale of 469,031 shares. During the past 18 months, 958,979 shares of Venus Concept Inc (VERO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 958,979 shares.

Venus Concept Inc (VERO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 35,287 shares made by Karen Noblett , a net sale of 32,884 shares made by Ford Alfred J Jr , and a net sale of 15,674 shares made by Danny L. Dearen .

In summary, during the past 3 months, insiders sold 2,961 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 2,961 shares. During the past 18 months, 141,355 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 141,355 shares.

Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Tricida Inc (TCDAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tricida Inc (TCDAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tricida Inc (TCDAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Collegium Pharmaceutical Inc (COLL). Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 198,212 shares made by Joseph Ciaffoni , a net sale of 88,809 shares made by Shirley R. Kuhlmann , and a net sale of 141,576 shares made by Scott Dreyer .

In summary, during the past 3 months, insiders sold 29,818 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 29,818 shares. During the past 18 months, 486,885 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,885 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 27,099 shares made by Mark T Iwicki , a net sale of 9,108 shares made by Romulus K Brazzell , and a net sale of 8,151 shares made by Todd Bazemore .

In summary, during the past 3 months, insiders sold 0 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 59,535 shares of Kala Bio Inc (KALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 59,535 shares.

Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .

In summary, during the past 3 months, insiders sold 34,101 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 34,101 shares. During the past 18 months, 551,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,899 shares.

Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,679 shares made by Eric Warren , a net purchase of 5,450 shares made by Sheldon L. Koenig , and a net sale of 4,202 shares made by Joanne M. Foody .

In summary, during the past 3 months, insiders sold 17,476 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 17,476 shares. During the past 18 months, 26,431 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 33,180 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sequenom Inc (SQNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sequenom Inc (SQNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sequenom Inc (SQNM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Rapid Micro Biosystems Inc (RPID). Other recent insider transactions involving Rapid Micro Biosystems Inc (RPID) include a net purchase of 124,000 shares made by Spignesi Robert G. Jr. , a net purchase of 20,000 shares made by Sean M Wirtjes , and a net purchase of 65,000 shares made by Richard S Kollender .

In summary, during the past 3 months, insiders sold 0 shares of Rapid Micro Biosystems Inc (RPID) in total and bought 175,000 shares, with a net purchase of 175,000 shares. During the past 18 months, 0 shares of Rapid Micro Biosystems Inc (RPID) were sold and 259,000 shares were bought by its insiders, resulting in a net purchase of 259,000 shares.

Rapid Micro Biosystems Inc (RPID)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Talaris Therapeutics Inc (TALS). Other recent insider transactions involving Talaris Therapeutics Inc (TALS) include a net sale of 218,472 shares made by Suzanne Ildstad ,

In summary, during the past 3 months, insiders sold 0 shares of Talaris Therapeutics Inc (TALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 21,847 shares of Talaris Therapeutics Inc (TALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 21,847 shares.

Talaris Therapeutics Inc (TALS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Vera Therapeutics Inc (VERA). Other recent insider transactions involving Vera Therapeutics Inc (VERA) include a net sale of 139,376 shares made by Marshall Fordyce , a net sale of 673,169 shares made by Maha Katabi , and a net sale of 601,783 shares made by Commodore Capital Lp .

In summary, during the past 3 months, insiders sold 165,642 shares of Vera Therapeutics Inc (VERA) in total and bought 0 shares, with a net sale of 165,642 shares. During the past 18 months, 2,182,482 shares of Vera Therapeutics Inc (VERA) were sold and 614,507 shares were bought by its insiders, resulting in a net sale of 1,567,975 shares.

Vera Therapeutics Inc (VERA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Patrick G Enright made no insider transaction in Lexeo Therapeutics Inc (LXEO). Other recent insider transactions involving Lexeo Therapeutics Inc (LXEO) include a net sale of 80,000 shares made by Richard Nolan Townsend , a net purchase of 454,545 shares made by Omega Fund Vi Gp, L.p. , and a net purchase of 454,545 shares made by Longitude Capital Partners Iv, Llc .

In summary, during the past 3 months, insiders sold 15,000 shares of Lexeo Therapeutics Inc (LXEO) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 80,000 shares of Lexeo Therapeutics Inc (LXEO) were sold and 1,136,362 shares were bought by its insiders, resulting in a net purchase of 1,056,362 shares.

Lexeo Therapeutics Inc (LXEO)'s detailed insider trading history can be found in Insider Trading Tracker table.